---
figid: PMC6158478__WJG-24-4132-g002
figlink: /pmc/articles/PMC6158478/figure/F2/
number: F2
caption: 'Biochemical pathways of lysophosphatidic acid synthesis and degradation.
  LPA can be produced extracellularly and intracellularly as signaling mediators and
  membrane components, respectively. There are five major pathways for LPA production,
  (1) the lysophospholipids-ATX (LPLs-ATX) pathway, (2) the phosphatidic acid - phospholipase
  A1 or A2 (PA-PLA1/PLA2) pathway, (3) the de novo glycerophosphate acyltransferase
  (GPAT) synthesis pathway, (4) the monoacylglycerol kinase (MAGK) pathway, and (5)
  the oxidative modification of low-density lipoprotein (LDL) pathway. In the upper
  right corner of the figure, there are catalytically active isoforms (ATXα, ATXβ,
  ATXγ, ATXδ and ATXε), which are expressed in different tissues. PLs: Phospholipids;
  PLA1/PLA2: Phospholipase A1/2; LPLs: Lysophospholipids; ATX: Autotaxin; ATXα-δ:
  Protein structure scheme of the domains of ATX; LPA: Lysophosphatidic acid; DAG:
  Diacylglycerol; DGK: Diacylglycerol kinase; PLD1/2: Phospholipase D1/2; PA: Phosphatidic
  acid; AGPAT: Acylglycerophosphate acyltransferase; MAG: Monoacylglycerol; MAGK:
  Monoacylglycerol kinase; LPP: Lipid phosphate phosphatase; G3P: Glycerol-3-phosphate;
  lyso PL: Lysophospholipase; GPAT: Glycerophosphate acyltransferase; LDL: Low-density
  lipoprotein; i: Intramembrane domain; SMB: N-terminal somatomedin B-like domains;
  L1: L1 linker region; PDF: Phosphodiesterase domain; L2: L2 linker region; NUC:
  C-terminal nuclease-like domain; LPA1-6: Lysophosphatidic acid receptor 1-6.'
pmcid: PMC6158478
papertitle: Production of extracellular lysophosphatidic acid in the regulation of
  adipocyte functions and liver fibrosis.
reftext: Fang Yang, et al. World J Gastroenterol. 2018 Sep 28;24(36):4132-4151.
pmc_ranked_result_index: '22967'
pathway_score: 0.7608724
filename: WJG-24-4132-g002.jpg
figtitle: Biochemical pathways of lysophosphatidic acid synthesis and degradation
year: '2018'
organisms:
- Homo sapiens
ndex: f78044eb-deef-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6158478__WJG-24-4132-g002.html
  '@type': Dataset
  description: 'Biochemical pathways of lysophosphatidic acid synthesis and degradation.
    LPA can be produced extracellularly and intracellularly as signaling mediators
    and membrane components, respectively. There are five major pathways for LPA production,
    (1) the lysophospholipids-ATX (LPLs-ATX) pathway, (2) the phosphatidic acid -
    phospholipase A1 or A2 (PA-PLA1/PLA2) pathway, (3) the de novo glycerophosphate
    acyltransferase (GPAT) synthesis pathway, (4) the monoacylglycerol kinase (MAGK)
    pathway, and (5) the oxidative modification of low-density lipoprotein (LDL) pathway.
    In the upper right corner of the figure, there are catalytically active isoforms
    (ATXα, ATXβ, ATXγ, ATXδ and ATXε), which are expressed in different tissues. PLs:
    Phospholipids; PLA1/PLA2: Phospholipase A1/2; LPLs: Lysophospholipids; ATX: Autotaxin;
    ATXα-δ: Protein structure scheme of the domains of ATX; LPA: Lysophosphatidic
    acid; DAG: Diacylglycerol; DGK: Diacylglycerol kinase; PLD1/2: Phospholipase D1/2;
    PA: Phosphatidic acid; AGPAT: Acylglycerophosphate acyltransferase; MAG: Monoacylglycerol;
    MAGK: Monoacylglycerol kinase; LPP: Lipid phosphate phosphatase; G3P: Glycerol-3-phosphate;
    lyso PL: Lysophospholipase; GPAT: Glycerophosphate acyltransferase; LDL: Low-density
    lipoprotein; i: Intramembrane domain; SMB: N-terminal somatomedin B-like domains;
    L1: L1 linker region; PDF: Phosphodiesterase domain; L2: L2 linker region; NUC:
    C-terminal nuclease-like domain; LPA1-6: Lysophosphatidic acid receptor 1-6.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLA2G2D
  - DGKK
  - PLPP3
  - MAG
  - PLA2G12A
  - PLA2G6
  - PLA2G4D
  - PLPP2
  - DGKI
  - PPAT
  - LPA
  - LPAR2
  - PLA2G7
  - DGKA
  - DGKB
  - DGKG
  - DGKH
  - PLA2G1B
  - PLA2G2A
  - PLA2G4A
  - DGKD
  - PLA2G2F
  - PLA2G2E
  - PLA2G2C
  - PLA2G5
  - DGKE
  - PLA2G3
  - PLA2G10
  - PLA2G12B
  - PLA2G4C
  - DGKQ
  - CTSC
  - DGKZ
  - LPA
  - 'N'
  - Oxidation damage
genes:
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2D
  entrez: '26279'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKK
  entrez: '139189'
- word: LPP1,2,3,x
  symbol: LPP3
  source: hgnc_alias_symbol
  hgnc_symbol: PLPP3
  entrez: '8613'
- word: MAG
  symbol: MAG
  source: hgnc_symbol
  hgnc_symbol: MAG
  entrez: '4099'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12A
  entrez: '81579'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G6
  entrez: '8398'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4D
  entrez: '283748'
- word: LPP1,2,3,x
  symbol: LPP2
  source: hgnc_alias_symbol
  hgnc_symbol: PLPP2
  entrez: '8612'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKI
  entrez: '9162'
- word: GPAT
  symbol: GPAT
  source: hgnc_alias_symbol
  hgnc_symbol: PPAT
  entrez: '5471'
- word: LPA
  symbol: LPA
  source: hgnc_symbol
  hgnc_symbol: LPA
  entrez: '4018'
- word: LPAR2
  symbol: LPAR2
  source: hgnc_symbol
  hgnc_symbol: LPAR2
  entrez: '9170'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G7
  entrez: '7941'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKA
  entrez: '1606'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKB
  entrez: '1607'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKG
  entrez: '1608'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKH
  entrez: '160851'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G1B
  entrez: '5319'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2A
  entrez: '5320'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4A
  entrez: '5321'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKD
  entrez: '8527'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2F
  entrez: '64600'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2E
  entrez: '30814'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2C
  entrez: '391013'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G5
  entrez: '5322'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKE
  entrez: '8526'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G3
  entrez: '50487'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G10
  entrez: '8399'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12B
  entrez: '84647'
- word: PLA:/PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4C
  entrez: '8605'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKQ
  entrez: '1609'
- word: PLs
  symbol: PLS
  source: hgnc_prev_symbol
  hgnc_symbol: CTSC
  entrez: '1075'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKZ
  entrez: '8525'
chemicals:
- word: LPA
  source: MESH
  identifier: C522988
- word: 'N'
  source: MESH
  identifier: D009584
diseases:
- word: Oxidation damage
  source: MESH
  identifier: D004194
figid_alias: PMC6158478__F2
redirect_from: /figures/PMC6158478__F2
figtype: Figure
---
